Literature DB >> 12938145

Interleukin-10 gene -627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma.

Liang-Wen Hang1, Te-Chun Hsia, Wen-Chi Chen, Huey-Yi Chen, Jeffrey J P Tsai, Fuu-Jen Tsai.   

Abstract

Asthma is an airway hyperresponsive disease characterized by the expression of multiple inflammatory genes, including cytokines. Interleukin-I and interleukin-10 (IL-1 and IL-10) are cytokines that might play a role in the process of inflammation and are therefore considered to be involved in the pathogenesis of bronchial asthma. The aim of this study was to test whether the polymorphisms of the promoter region and exon 5 of the IL-1 gene, intron 2 of the IL-1Ra gene, and -627 nucleotide (C/A) of the IL-10 gene could be genetic markers for the susceptibility of bronchial asthma. A normal control group made up of 47 healthy volunteers and 117 patients with bronchial asthma were examined in this study. We analyzed the variable number of tandem repeats at intron 2 of the IL-1Ra gene for the polymorphisms by polymerase chain reaction (PCR). PCR-based restriction analysis of the IL-1 gene polymorphisms of the promoter region and exon 5 was carried out by the endonucleases Ava I and Taq I, respectively. The IL-10 gene -627 C/A polymorphisms were investigated by PCR-based restriction analysis. The distribution of CC homozygotes in the IL-10 gene was significantly lower in asthma patients than in controls (P=0.013, OR=3.599, 95% CI=1.240 approximately 10.441). The polymorphisms studied in the IL-1 genes did not reveal any significant association with bronchial asthma when compared with the control group (promoter region by chi-square test, P=0.627; exon 5 region by Fisher's exact test, P=0.403). Only two alleles of the IL-1Ra gene corresponding to one and two copies of an 86-base pair sequence repeat were identified by PCR in the control group. There were three alleles found in the asthmatic patient group. The results revealed no significant differences between normal individuals and asthma patients (P=0.454, Fisher's exact test). The IL-10 gene -627 "A" allele is an associated risk factor of developing atopic asthma. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938145      PMCID: PMC6808065          DOI: 10.1002/jcla.10088

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

1.  Haplotype associated with low interleukin-10 production in patients with severe asthma.

Authors:  S Lim; E Crawley; P Woo; P J Barnes
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

2.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

Authors:  J C Mansfield; H Holden; J K Tarlow; F S Di Giovine; T L McDowell; A G Wilson; C D Holdsworth; G W Duff
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

3.  IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization.

Authors:  M J Mäkelä; A Kanehiro; L Borish; A Dakhama; J Loader; A Joetham; Z Xing; M Jordana; G L Larsen; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle.

Authors:  H Hakonarson; N Maskeri; C Carter; S Chuang; M M Grunstein
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci.

Authors:  A Steinkasserer; N K Spurr; S Cox; P Jeggo; R B Sim
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

Review 6.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 7.  Biologic activities of IL-1 and its role in human disease.

Authors:  L J Rosenwasser
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

8.  Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release.

Authors:  M Marini; M Soloperto; M Mezzetti; A Fasoli; S Mattoli
Journal:  Am J Respir Cell Mol Biol       Date:  1991-06       Impact factor: 6.914

9.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff
Journal:  J Invest Dermatol       Date:  1994-09       Impact factor: 8.551

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  12 in total

1.  Serum Clara cell protein and atopic phenotype in children up to 2 years of age.

Authors:  Nevenka Ilic; Natasa Mihailovic
Journal:  J Clin Lab Anal       Date:  2017-02-01       Impact factor: 2.352

Review 2.  Genetic studies of the etiology of asthma.

Authors:  Kathleen C Barnes
Journal:  Proc Am Thorac Soc       Date:  2011-05

Review 3.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

Review 4.  Interleukin-10 Gene Promoter Polymorphisms and Susceptibility to Asthma: Systematic Review and Meta-analysis.

Authors:  Danyal Imani; Navid Dashti; Arash Parvari; Sajad Shafiekhani; Fatemeh Alebrahim; Bahman Razi; Masoud Hassanzadeh Makoui; Morteza Motallebnezhad; Saeed Aslani; Mansur Aliyu
Journal:  Biochem Genet       Date:  2021-03-23       Impact factor: 1.890

5.  Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy.

Authors:  Byung Lae Park; Lyoung Hyo Kim; Yoo Hyun Choi; June-Hyuk Lee; Taiyoun Rhim; Young Mok Lee; Soo-Taek Uh; Hae-Sim Park; Byoung Whui Choi; Soo-Jong Hong; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2004-09-11       Impact factor: 3.172

6.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

7.  IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.

Authors:  Dawn L Demeo; Edward J Campbell; Alan F Barker; Mark L Brantly; Edward Eden; N Gerard McElvaney; Stephen I Rennard; Robert A Sandhaus; James M Stocks; James K Stoller; Charlie Strange; Gerard Turino; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-09       Impact factor: 6.914

Review 8.  Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis.

Authors:  Xue-yan Zheng; Wei-jie Guan; Chen Mao; Hui-fang Chen; Hong Ding; Jin-ping Zheng; Ting-ting Hu; Min-hong Luo; Yan-hui Huang; Qing Chen
Journal:  Lung       Date:  2013-10-27       Impact factor: 2.584

9.  Recommendations for using standardised phenotypes in genetic association studies.

Authors:  Melissa G Naylor; Scott T Weiss; Christoph Lange
Journal:  Hum Genomics       Date:  2009-07       Impact factor: 4.639

10.  Interleukin-10 promoter gene polymorphisms and susceptibility to asthma: a meta-analysis.

Authors:  Myung-Han Hyun; Chung-Ho Lee; Min-Hyung Kang; Bong-Kyung Park; Young Ho Lee
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.